Neda Razavi on Blogger: Bluebird Bio Launches First Gene Therapy for Beta Thalassemia

About Neda Razavi

Neda Razavi is a respected presence in the Northern California pharmaceutical commercial sphere and serves as an executive marketing consultant and brand leader with Natera. Her work with the genetic testing enterprise centers on guiding cross-functional teams and building brand loyalty in ways that translate to increased market share. Successful in helping to transition the firm to a positive revenue footing, Neda Razavi has employed strategies such as referral programs, social media strategy, professional programs, and tactical upselling in boosting attachment rates.

Ms. Razavi’s experience extends to Medtronic in Northridge as a group marketing manager, where she led efforts centered on global glucose monitoring products. A particular accomplishment was discovering an untapped $650 million opportunity that allowed for market penetration with low investment and significantly enhanced margins. She also oversaw the repositioning of a device in development to target the type 2 Diabetes market and gained development funding.

With an undergraduate degree in microbiology and cellular biology, Ms. Razavi earned her MBA in finance at Pepperdine University and is continuing her studies at the Stanford University School of Professional Development. Neda Razavi is also working toward a genetics and genomics certificate at Stanford University.

Tuesday, May 5, 2020

Bluebird Bio Launches First Gene Therapy for Beta Thalassemia